HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Novel Role for IL-6 Receptor Classic Signaling: Induction of RORγt+Foxp3+ Tregs with Enhanced Suppressive Capacity.

AbstractBACKGROUND:
New therapies blocking the IL-6 receptor (IL-6R) have recently become available and are successfully being used to treat inflammatory diseases like arthritis. Whether IL-6 blockers may help patients with kidney inflammation currently remains unknown.
METHODS:
To learn more about the complex role of CD4+ T cell-intrinsic IL-6R signaling, we induced nephrotoxic nephritis, a mouse model for crescentic GN, in mice lacking T cell-specific IL-6Ra. We used adoptive transfer experiments and studies in reporter mice to analyze immune responses and Treg subpopulations.
RESULTS:
Lack of IL-6Ra signaling in mouse CD4+ T cells impaired the generation of proinflammatory Th17 cells, but surprisingly did not ameliorate the course of GN. In contrast, renal damage was significantly reduced by restricting IL-6Ra deficiency to T effector cells and excluding Tregs. Detailed studies of Tregs revealed unaltered IL-10 production despite IL-6Ra deficiency. However, in vivo and in vitro, IL-6Ra classic signaling induced RORγt+Foxp3+ double-positive Tregs (biTregs), which carry the trafficking receptor CCR6 and have potent immunoregulatory properties. Indeed, lack of IL-6Ra significantly reduced Treg in vitro suppressive capacity. Finally, adoptive transfer of T cells containing IL-6Ra-/- Tregs resulted in severe aggravation of GN in mice.
CONCLUSIONS:
Our data refine the old paradigm, that IL-6 enhances Th17 responses and suppresses Tregs. We here provide evidence that T cell-intrinsic IL-6Ra classic signaling indeed induces the generation of Th17 cells but at the same time highly immunosuppressive RORγt+ biTregs. These results advocate caution and indicate that IL-6-directed therapies for GN need to be cell-type specific.
AuthorsJulia Hagenstein, Simon Melderis, Anna Nosko, Matthias T Warkotsch, Johannes V Richter, Torben Ramcke, Georg R Herrnstadt, Jürgen Scheller, Isabell Yan, Hans-Willi Mittrücker, Malte A Kluger, Oliver M Steinmetz
JournalJournal of the American Society of Nephrology : JASN (J Am Soc Nephrol) Vol. 30 Issue 8 Pg. 1439-1453 (08 2019) ISSN: 1533-3450 [Electronic] United States
PMID31311828 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 by the American Society of Nephrology.
Chemical References
  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • Il6ra protein, mouse
  • Immunosuppressive Agents
  • Interleukin-6 Receptor alpha Subunit
  • Nuclear Receptor Subfamily 1, Group F, Member 3
  • Receptors, Interleukin-6
  • Rorc protein, mouse
Topics
  • Animals
  • Cell Line
  • Crosses, Genetic
  • Female
  • Forkhead Transcription Factors (metabolism)
  • Glomerulonephritis (metabolism, pathology)
  • Immunosuppressive Agents (therapeutic use)
  • Inflammation
  • Interleukin-6 Receptor alpha Subunit (genetics, metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Necrosis
  • Nuclear Receptor Subfamily 1, Group F, Member 3 (metabolism)
  • Receptors, Interleukin-6 (genetics, metabolism)
  • Signal Transduction
  • T-Lymphocytes, Regulatory (immunology)
  • Th17 Cells (cytology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: